The European Commission has approved the subcutaneous (SC) formulation of DARZALEX (daratumumab) in combination with ...

The National Institute for Health and Care Excellence (NICE) has announced that people with heart failure can now stay healthier remotely through advanced remote monitoring technology designed to ...

PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative ...

The two-year programme will use virtual reality technology to teach essential skills A £4.5m initiative has been launched to address the growing skills shortage in the UK’s medicines manufacturing ...

Dundee-based Ubiquigent Limited and San Francisco’s Alleo Labs Corp have entered a strategic partnership to advance deubiquitinase (DUB)-focused drug discovery using AI. The collaboration aims to ...

As the polls tighten and June’s general election starts to seem very close indeed, we’ve got a roundup of all the major parties’ manifestos and what they would mean for healthcare in the UK. But ...

When I spoke to you last month Boris Johnson was Prime Minister and HM Elizabeth II was Head of State. There are, indeed, decades where nothing happens and there are weeks when decades happen. And, in ...

There are around 55,100 new prostate cancer cases in the UK every year HBC Immunology (HBCI) has announced that an oral formulation of its lead peptide “significantly augmented” the anti-tumour ...

The 2018 Communications Team of the Year awards are now open for entry, so on p32 we thought we’d ask some top pharma communicators what trends and issues comms teams need to be paying attention to ...

The London hub is home to life sciences companies including Novartis, Engitix and invoX Pharma Vivan Therapeutics has signed a new five-year lease at White City Place, a biotech hub in London home to ...